Table 2.
Outcome | Any decrease (n=308) | No decrease (n=321) | P value |
Best overall response—no. (%) | 0.04 | ||
Complete response (CR) | 31 (10.1) | 37 (11.5) | |
Partial response (PR) | 54 (17.5) | 85 (26.5) | |
Stable disease (SD) | 56 (18.2) | 58 (18.1) | |
Progressive disease (PD) | 162 (52.6) | 135 (42.1) | |
Could not be evaluated | 5 (1.6) | 6 (1.9) | |
Objective response rate* | 0.01 | ||
No. (%) | 85 (27.6) | 122 (38.0) | |
95% CI† | 22.7 to 33.0 | 32.7 to 43.6 | |
Disease control rate‡ | 0.01 | ||
No. (%) | 141 (45.8) | 180 (56.1) | |
95% CI† | 40.1 to 51.5 | 50.1 to 61.6 |
*Objective response rate was defined as the percentage of patients who had CR or PR.
†The 95% CIs were calculated using the Clopper-Pearson method.
‡Disease control rate was defined as the percentage of patients who had CR, PR or SD